🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So exciting to see practical neurotechnology making its way to market. Looking forward to the not-too-distant future of wearable bci. spectrum.ieee.org/view-from-the-…

Cool new evidence suggesting why we can only go so far with feed-forward CNNs by my former classmate Elias Issa and CBMM. Summary here: medicalxpress.com/news/2019-04-d… and original (paywalled) publication via Nature Neuroscience here: nature.com/articles/s4159….

No matter how impressive you think today's technology is, reflect on the fact that the little lump of tissue inside our skull consumes a million times less power than the word's most powerful supercomputer, and probably does a million times more things. the-scientist.com/features/build…

Truly an amazing accomplishment by Allen Institute, Andreas Tolias Lab @ Stanford University, and Sebastian Seung. It was about 10 years ago when Clay Reid, JoVo NeuroData Lab and I first discussed the vision for MICrONS. Clay said he could get the data if I could get the money. I think we both delivered =)

This is really an amazing accomplishment. Congrats to Davi Bock and his team at HHMI | Janelia. So - who is going to be the first one to build me a fly brain on a chip?

Ethical commercialization of neurotechnology is critical for the long-term health of the industry. Too many unsubstantiated claims on what these 1st-gen devices can do, and how they do it, will undermine the credibility of future (more legit) products cell.com/neuron/fulltex…

I've seen the Gigantum product evolve for two years now and while it was good then, it is great now, and will be even more awesome soon! Check out this post from eLife Innovation on how it can be used to achieve truly reproducible research

I find many neuroethicists a bit sanctimonious, but I wonder if the medtech VC community should consider how we can support patients with implanted devices after the startups that created them go out of business. nature.com/articles/d4158…

It was truly a privilege to work with the connectomics community to create this project at IARPA. Looking forward to seeing how it all turns out! nature.com/articles/d4158…

Looking good, Mark Chevillet ! After all of the hype generated by Neuralink, it's refreshing to see some people thinking about practical neurotechnology for consumers. Keep up the good work at Facebook Reality! tech.fb.com/imagining-a-ne…

Amazing work. Not sure how long it will be, but some day in the future the price of a connectome will be the same as the price of a genome today. ai.googleblog.com/2019/08/an-int…

This is, on the one hand, completely predictable. On the other hand, it's still cool that it worked. Complex artificial memories are still a long way away, but this Nature paper shows that simple aversive or attractive associations can be written in now. scientificamerican.com/article/a-succ…

In case anyone would enjoy a 30 minute video update on the IARPA #MICrONS program and some of the exciting things we're learning from cortical connectomes, here's my briefing to NIH BRAIN leadership last week. Starting at 43:15: videocast.nih.gov/summary.asp?li…

We are pleased to announce our investment in ⁦⁦Compass Pathways⁩ along with Founders Fund atai Life Sciences & other great investors. In today's world, mental health is more important than ever, & COMPASS is leading the charge for next-gen therapies. fiercebiotech.com/biotech/compas…

High-risk government R&D creates a lot of economic value! The IARPA MICrONS program awarded contracts in Jan 2016. Teams have since spun off 11 companies with ~$120M of private funding. First two exits, in 2020, were for $40M and $350M, respectively.

Our oversubscribed Catalio Nexus Fund II closed at its hard cap of $100M! Thanks to all of our investors, venture partners, team members, and friends who helped us achieve this milestone - we are incredibly grateful for your commitment and support!

We couldn't be more excited to announce the sale of Thrive Earlier Detection to Exact Sciences (NASDAQ:EXAS) for $2.15B. Huge congrats to Thrive founders Nick Papadopoulos, Ken Kinzler & Catalio Venture Partner Bert Vogelstein (also scientific co-founder of Exact) marketwatch.com/story/exact-sc…

Proud to announce the launch of HealthCor Catalio Acquisition Corp. (NASDAQ: HCAQ), our first SPAC, in collaboration with our good friends at HealthCor Management. HCAQ started trading today, after an upsized $180M IPO.

It is humbling to make the ⁦Endpoints News⁩ & ⁦DealForma list of the top biopharma investors within our first year of operations, alongside industry veterans.⁩ hubs.ly/H0HC-4x0 hubs.ly/H0HC-4x0

We are proud to announce the close of our 3rd VC fund to invest in category-defining life science companies around the globe. With this fund we have grown over 10x since our launch in 2020. Thank you to our investors and teammates for believing in us! wsj.com/articles/catal…